224 related articles for article (PubMed ID: 17973895)
1. New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review.
Panzer S
Vox Sang; 2008 Jan; 94(1):1-5. PubMed ID: 17973895
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
Chouhan JD; Herrington JD
Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances in the treatment of idiopathic thrombocytopenic purpura].
Kurata Y
Rinsho Ketsueki; 2007 May; 48(5):355-62. PubMed ID: 17571579
[No Abstract] [Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
[TBL] [Abstract][Full Text] [Related]
5. Emerging strategies to treat chronic immune thrombocytopenic purpura.
Newland A
Eur J Haematol Suppl; 2008 Feb; (69):27-33. PubMed ID: 18211570
[TBL] [Abstract][Full Text] [Related]
6. New options after first-line therapy for chronic immune thrombocytopenic purpura.
Burzynski J
Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S11-21. PubMed ID: 19139486
[TBL] [Abstract][Full Text] [Related]
7. Two new drugs for chronic ITP.
Med Lett Drugs Ther; 2009 Feb; 51(1305):10-1. PubMed ID: 19197233
[TBL] [Abstract][Full Text] [Related]
8. Positioning new treatments in the management of immune thrombocytopenia.
Arnold DM
Pediatr Blood Cancer; 2013; 60 Suppl 1(Suppl 1):S19-22. PubMed ID: 23109488
[TBL] [Abstract][Full Text] [Related]
9. New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses.
Arnold DM; Nazi I; Kelton JG
Expert Opin Investig Drugs; 2009 Jun; 18(6):805-19. PubMed ID: 19426124
[TBL] [Abstract][Full Text] [Related]
10. [New treatment options for primary immune thrombocytopenia].
Gudbrandsdottir S; Frederiksen H; Birgens HS; Nielsen CH; Nielsen OJ; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2011 Jan; 173(4):271-4. PubMed ID: 21262171
[TBL] [Abstract][Full Text] [Related]
11. Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP).
Boyers D; Jia X; Crowther M; Jenkinson D; Fraser C; Mowatt G
Health Technol Assess; 2011 May; 15 Suppl 1():23-32. PubMed ID: 21609650
[TBL] [Abstract][Full Text] [Related]
12. Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis.
Puavilai T; Thadanipon K; Rattanasiri S; Ingsathit A; McEvoy M; Attia J; Thakkinstian A
Br J Haematol; 2020 Feb; 188(3):450-459. PubMed ID: 31423574
[TBL] [Abstract][Full Text] [Related]
13. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
Kuter DJ
Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
[TBL] [Abstract][Full Text] [Related]
14. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura.
Nurden AT; Viallard JF; Nurden P
Lancet; 2009 May; 373(9674):1562-9. PubMed ID: 19324405
[TBL] [Abstract][Full Text] [Related]
15. [Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?].
Godeau B;
Rev Med Interne; 2009 Mar; 30(3):203-5. PubMed ID: 19019500
[No Abstract] [Full Text] [Related]
16. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
17. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
Tamary H; Roganovic J; Chitlur M; Nugent DJ
Ann Hematol; 2010 Jul; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
[TBL] [Abstract][Full Text] [Related]
18. Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.
Altomare I; Wasser J; Pullarkat V
Am J Hematol; 2012 Oct; 87(10):984-7. PubMed ID: 22729832
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options for adult patients with previously treated immune thrombocytopenia - a systematic review and network meta-analysis.
Yang R; Lin L; Yao H; Ji O; Shen Q
Hematology; 2019 Dec; 24(1):290-299. PubMed ID: 30661482
[TBL] [Abstract][Full Text] [Related]
20. New insights and therapeutics for immune-mediated thrombocytopenia.
Metjian A; Abrams CS
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):71-84. PubMed ID: 18095908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]